Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
The high rate of metastasis and recurrence among melanoma patients indicates the existence of cells within melanoma that have the ability to both initiate metastatic programs and bypass immune recognition. Here, we identify CD47 as a regulator of melanoma tumor metastasis and immune evasion. Protein...
Main Authors: | Michael Ngo, Arum Han, Anita Lakatos, Debashis Sahoo, Stephanie J. Hachey, Kipp Weiskopf, Andrew H. Beck, Irving L. Weissman, Alexander D. Boiko |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716308907 |
Similar Items
-
Decoding the Role of CD271 in Melanoma
by: Anna Vidal, et al.
Published: (2020-08-01) -
Imaging of CD47 Expression in Xenograft and Allograft Tumor Models
by: Alexander Zheleznyak, et al.
Published: (2013-11-01) -
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
by: Maria Cristina Petralia, et al.
Published: (2019-07-01) -
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
by: Betancur, Paola A., et al.
Published: (2017) -
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
by: Paola A. Betancur, et al.
Published: (2017-04-01)